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Background/Introduction
True node-negative small sized non-small cell lung cancers are optimal candidates for sublobar resection without systematic lymph node dissection.
Aims/Objectives
The purpose of this study is to identify the predictive factors of true node-negative clinical stage IA non-small cell lung cancer.
Method
A multicenter database of patients with completely resected clinical stage IA lung adenocarcinoma (n = 502) or squamous cell carcinoma (n = 100) was retrospectively analyzed. The relationship between lymph node status and preoperative factors such as tumor size on HRCT and maximum standardized uptake value (SUVmax) on FDG-PET/CT were examined.
Results
Multivariate analyses revealed that solid tumor size on HRCT (Odds ratio (OR), 1.42; p < 0.001) or SUVmax on FDG-PET/CT (OR, 1.04; p = 0.049) was identified as an independent predictor of lymph node metastasis in patients with lung adenocarcinoma. The predictive criteria of node-negative lung adenocarcinoma were solid tumor size <0.8 cm or SUVmax <1.5. Among patients who met the node-negative criteria, recurrence-free survival at 5 years was not significantly different between those who underwent lobectomy (96.0%) and those who underwent sublobar resection (97.2%). In patients with squamous cell carcinoma of the lung, no independent predictive factors for lymph node metastasis were identified in univariate or multivariate analysis.
Discussion/Conclusion
Either solid tumor size on HRCT or SUVmax on FDG-PET/CT was a significant independent predictor of nodal status in clinical stage IA lung adenocarcinoma. The node-negative criteria of solid tumor size <0.8 cm or SUVmax <1.5 are helpful for choosing candidates for sublobar resection without systematic lymphadenectomy. In patients with clinical stage IA lung squamous cell carcinoma, systematic lymphadenectomy is advisable.
